Corient Private Wealth LLC bought a new position in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 68,821 shares of the company's stock, valued at approximately $1,345,000. Corient Private Wealth LLC owned 0.06% of Privia Health Group as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Park Avenue Securities LLC lifted its position in Privia Health Group by 3.8% in the fourth quarter. Park Avenue Securities LLC now owns 14,697 shares of the company's stock valued at $287,000 after purchasing an additional 532 shares during the period. PNC Financial Services Group Inc. lifted its holdings in shares of Privia Health Group by 8.0% in the 4th quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company's stock valued at $140,000 after buying an additional 533 shares during the period. First Horizon Advisors Inc. boosted its stake in shares of Privia Health Group by 53.8% in the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock valued at $35,000 after buying an additional 632 shares in the last quarter. HighTower Advisors LLC grew its holdings in Privia Health Group by 5.0% during the fourth quarter. HighTower Advisors LLC now owns 19,469 shares of the company's stock worth $381,000 after acquiring an additional 932 shares during the period. Finally, US Bancorp DE raised its position in Privia Health Group by 6.7% in the fourth quarter. US Bancorp DE now owns 18,058 shares of the company's stock worth $353,000 after acquiring an additional 1,134 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company's stock.
Privia Health Group Stock Performance
Shares of PRVA stock traded down $0.33 during trading hours on Friday, hitting $22.59. The company had a trading volume of 757,835 shares, compared to its average volume of 773,534. Privia Health Group, Inc. has a 12 month low of $15.92 and a 12 month high of $26.04. The firm's fifty day moving average is $23.80 and its 200 day moving average is $21.18. The firm has a market capitalization of $2.72 billion, a price-to-earnings ratio of 225.92, a PEG ratio of 3.47 and a beta of 0.85.
Analysts Set New Price Targets
A number of research firms have recently weighed in on PRVA. JPMorgan Chase & Co. upped their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an "overweight" rating in a research note on Friday, November 29th. Canaccord Genuity Group increased their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a report on Friday, February 28th. Piper Sandler boosted their price target on Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a research note on Friday, February 28th. Needham & Company LLC reaffirmed a "buy" rating and set a $30.00 price objective on shares of Privia Health Group in a report on Friday, March 21st. Finally, JMP Securities set a $29.00 target price on Privia Health Group in a report on Friday, February 28th. One research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of $26.67.
View Our Latest Analysis on PRVA
About Privia Health Group
(
Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
See Also
Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
